Revolution Medicines Statistics Share Statistics Revolution Medicines has 186.93M
shares outstanding. The number of shares has increased by 2.51%
in one year.
Shares Outstanding 186.93M Shares Change (YoY) 2.51% Shares Change (QoQ) 0.36% Owned by Institutions (%) 99.99% Shares Floating 158.53M Failed to Deliver (FTD) Shares 17,935 FTD / Avg. Volume 0.92%
Short Selling Information The latest short interest is 18.05M, so 9.66% of the outstanding
shares have been sold short.
Short Interest 18.05M Short % of Shares Out 9.66% Short % of Float 10.28% Short Ratio (days to cover) 8.01
Valuation Ratios The PE ratio is -12.23 and the forward
PE ratio is -7.73.
Revolution Medicines's PEG ratio is
1.69.
PE Ratio -12.23 Forward PE -7.73 PS Ratio 0 Forward PS 336.4 PB Ratio 3.24 P/FCF Ratio -12.92 PEG Ratio 1.69
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Revolution Medicines.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 14.2,
with a Debt / Equity ratio of 0.06.
Current Ratio 14.2 Quick Ratio 14.2 Debt / Equity 0.06 Debt / EBITDA -0.23 Debt / FCF -0.24 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-974.18K Employee Count 616 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax 753K Effective Tax Rate -0.13%
Stock Price Statistics The stock price has increased by -0.93% in the
last 52 weeks. The beta is 1.26, so Revolution Medicines's
price volatility has been higher than the market average.
Beta 1.26 52-Week Price Change -0.93% 50-Day Moving Average 39.82 200-Day Moving Average 39.72 Relative Strength Index (RSI) 61.04 Average Volume (20 Days) 1,953,882
Income Statement
Revenue n/a Gross Profit -592.23M Operating Income -689.52M Net Income -600.09M EBITDA -589.02M EBIT -600.85M Earnings Per Share (EPS) -3.58
Full Income Statement Balance Sheet The company has 543.06M in cash and 135.84M in
debt, giving a net cash position of 407.22M.
Cash & Cash Equivalents 543.06M Total Debt 135.84M Net Cash 407.22M Retained Earnings -1.74B Total Assets 2.43B Working Capital 1.99B
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -557.44M
and capital expenditures -10.31M, giving a free cash flow of -567.74M.
Operating Cash Flow -557.44M Capital Expenditures -10.31M Free Cash Flow -567.74M FCF Per Share -3.38
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
